Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

-$0.04 (-5.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.65

+$0.03 (+4.95%)

Pre-market: Nov 2, 2026, 7:51 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	910K	610K	367K	n/a	n/a	n/a	n/a	n/a
Gross Profit	-910K	-610K	-367K	n/a	n/a	n/a	n/a	n/a
Operating Income	-45.97M	-81.97M	-95.39M	-111.33M	-130.09M	-84.7M	-60.11M	-30.62M
Interest Income	3.68M	4.14M	4.62M	5.45M	6.9M	5.68M	4.42M	2.62M
Pretax Income	-42.28M	-77.9M	-90.97M	-106.03M	-123.17M	-78.94M	-55.54M	-27.94M
Net Income	-42.28M	-77.9M	-90.97M	-106.03M	-123.17M	-78.94M	-55.54M	-27.94M
Selling & General & Admin	29.41M	63.89M	68.43M	68.06M	73.1M	32.82M	21.9M	12.95M
Research & Development	15.66M	17.47M	26.59M	43.27M	56.99M	51.87M	38.21M	17.68M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	45.06M	81.36M	95.02M	111.33M	130.09M	84.7M	60.11M	30.62M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	45.97M	81.97M	95.39M	111.33M	130.09M	84.7M	60.11M	30.62M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	48.1M	47.98M
Shares Outstanding (Diluted)	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	4.81B	47.98M
EPS (Basic)	-0.87	-1.61	-1.88	-2.19	-2.55	-1.63	-1.15	-0.58
EPS (Diluted)	-0.87	-1.61	-1.88	-2.19	-2.55	-1.63	-1.15	-0.58
EBITDA	-42.03M	-76.94M	-90.04M	-107.92M	-124.93M	-80.93M	-57.74M	-27.68M
EBIT	-43.07M	-77.9M	-90.97M	-108.75M	-125.89M	-81.67M	-58.26M	-27.94M
Depreciation & Amortization	1.04M	959K	936K	829K	957K	739K	519K	259K